Lioton

Heparin Sodium, the active ingredient in Lioton, is an anticoagulant presented as a topical preparation for external use. Available in the European Union, the formulation is designed for easy application on affected skin areas and is employed to manage superficial clotting disorders and related skin conditions in adult patients.

GNH USA supplies Lioton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant documentation for cross‑border distribution.

Lioton (heparin sodium) is used topically to address conditions involving superficial clot formation and related inflammation.

Superficial thrombophlebitis: reduces clot formation and inflammation in affected veins. Bruising and hematoma: promotes resorption of localized blood collections and eases discomfort. Venous stasis dermatitis: improves microcirculation and decreases edema in chronic venous insufficiency.

Topical application of heparin sodium may be associated with local and systemic adverse reactions.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Erythema: localized redness without swelling. - Itching: transient pruritus where the product is applied. - Mild burning sensation: brief warmth that subsides quickly.

Serious or Rare Side Effects: - Allergic reaction: contact dermatitis or urticaria requiring medical attention. - Severe skin necrosis: tissue death at the site of application. - Systemic bleeding: unexpected bruising or hemorrhage beyond the treated area. - Thrombocytopenia: reduced platelet count that may increase bleeding risk. - Anaphylaxis: rare life‑threatening hypersensitivity reaction. - Delayed wound healing: prolonged recovery of skin lesions.

When using Lioton, several safety considerations should be observed to minimize risks.

Assess bleeding risk: evaluate patient history for coagulopathies or concurrent anticoagulant therapy. Avoid use on open wounds: apply only to intact skin. Do not combine with systemic anticoagulants without monitoring: coordinate with healthcare provider. Discontinue if signs of hypersensitivity appear: stop application and seek medical advice. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Heparin sodium can interact with other agents that affect haemostasis or increase bleeding risk.

Major Interactions (Avoid): - Concurrent systemic heparin therapy: additive anticoagulant effect may cause severe bleeding. - Use with other anticoagulants (warfarin, direct oral anticoagulants): heightened risk of hemorrhage. - Combination with thrombolytic agents (alteplase, streptokinase): may lead to uncontrolled bleeding.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may potentiate bleeding tendency. - Antiplatelet agents (aspirin, clopidogrel): increase risk of minor bleeding. - Herbal products with anticoagulant properties (ginkgo, garlic, ginger): monitor for excessive bruising.